Protective and Therapeutic Capacity of Human Single-Chain Fv-Fc Fusion Proteins against West Nile Virus

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Virology

• Publication date

  2005-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.79.23.14606-14613.2005PMID 16282460PMCID PMC1287547
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus

  2005influential reference
• West Nile Virus

  2005cited by this paper
• Use of Interferon-α in Patients with West Nile Encephalitis: Report of 2 Cases

  2005cited by this paper
• A recombinant envelope protein vaccine against West Nile virus.

  2005cited by this paper
• Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases.

  2005cited by this paper
• Calgary Experience with West Nile Virus Neurological Syndrome During the Late Summer of 2003

  2004cited by this paper
• West Nile virus: a growing concern?

  2004cited by this paper
• Detection of Human Anti-Flavivirus Antibodies with a West Nile Virus Recombinant Antigen Microsphere Immunoassay

  2004cited by this paper
• Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association.

  2004cited by this paper
• Epitope Determinants of a Chimpanzee Fab Antibody That Efficiently Cross-Neutralizes Dengue Type 1 and Type 2 Viruses Map to Inside and in Close Proximity to Fusion Loop of the Dengue Type 2 Virus Envelope Glycoprotein

  2004cited by this paper
• Chimpanzee Fab Fragments and a Derived Humanized Immunoglobulin G1 Antibody That Efficiently Cross-Neutralize Dengue Type 1 and Type 2 Viruses

  2004cited by this paper
• Human immunoglobulin as a treatment for West Nile virus infection.

  2003cited by this paper
• Inhibition of Tat-mediated Transactivation and HIV-1 Replication by Human Anti-hCyclinT1 Intrabodies*

  2003cited by this paper
• The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis.

  2003cited by this paper
• Antibody Prophylaxis and Therapy against West NileVirus Infection in Wild-Type and ImmunodeficientMice

  2003cited by this paper
• Antibody-Dependent Enhancement of Virus Infection and Disease

  2003influential reference
• Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis

  2002cited by this paper
• Efficacy of Interferon α-2b and Ribavirin against West Nile Virus In Vitro

  2002cited by this paper
• Efficacy of Killed Virus Vaccine, Live Attenuated Chimeric Virus Vaccine, and Passive Immunization for Prevention of West Nile virus Encephalitis in Hamster Model

  2002cited by this paper
• West Nile Virus

  2002cited by this paper
• A divalent antibody format is required for neutralization of human cytomegalovirus via antigenic domain 2 on glycoprotein B.

  2002cited by this paper
• Selection of single chain variable fragments (scFv) against the glycoprotein antigen of the rabies virus from a human synthetic scFv phage display library and their fusion with the Fc region of human IgG1

  2001cited by this paper
• Antibody Prophylaxis and Therapy for Flavivirus Encephalitis Infections

  2001cited by this paper
• Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000.

  2001cited by this paper
• Treatment of West Nile virus encephalitis with intravenous immunoglobulin.

  2001cited by this paper
• West Nile virus: a reemerging global pathogen.

  2001cited by this paper
• West Nile encephalitis: an emerging disease in the United States.

  2001cited by this paper
• Expression of single-chain Fv-Fc fusions in Pichia pastoris.

  2001cited by this paper
• Immunization of Mice Against West Nile Virus with Recombinant Envelope Protein1

  2001cited by this paper
• Antibodies for the prevention and treatment of viral diseases.

  2000cited by this paper
• Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells.

  2000cited by this paper
• Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut.

  1999cited by this paper
• Single-chain Fv radioimmunotargeting.

  1996cited by this paper
• Cyclophosphamide-potentiated West Nile viral encephalitis: relative influence of cellular and humoral factors.

  1974cited by this paper

• A Scoping Review of Preclinical Research on Monoclonal Antibody Development for Prophylaxis and Treatment of West Nile Virus Infections

  2025influential citation
• Adenoviral Vectors Expressing Optimized preM/E Genes of WNV Deliver Long-Term Protection Against Lethal West Nile Virus Challenge

  2025cites this paper
• Epitope(s) involving amino acids of the fusion loop of Japanese encephalitis virus envelope protein is(are) important to elicit protective immunity

  2024cites this paper
• Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections

  2023cites this paper
• Engineering the Single Domain Antibodies Targeting Receptor Binding Motifs Within the Domain III of West Nile Virus Envelope Glycoprotein

  2022cites this paper
• Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy

  2021cites this paper
• Neutralizing Potential of Fab IgG Hybrid Antibody Against Dengue Virus (DENV-1,2,3,4) Expressed on Mesenchymal Stem Cells

  2020cites this paper
• Identification of a linear epitope within domain I of Duck Tembusu virus envelope protein using a novel neutralizing monoclonal antibody.

  2020cites this paper
• A Molecular Determinant of West Nile Virus Secretion and Morphology as a Target for Viral Attenuation

  2020cites this paper
• Isolation of Antibody Binders to MISIIR from a Phage Display Library by Sorting.

  2020cites this paper
• Cloning, expression & evaluation of potential immunogenic recombinant capsid premembrane protein of West Nile virus

  2019cites this paper
• Designing antibody against highly conserved region of dengue envelope protein by in silico screening of scFv mutant library

  2019cites this paper
• La protéine non-structurale NS1 du virus West Nile : étude fonctionnelle et cible potentielle de nouvelles molécules antivirales

  2018cites this paper
• A potently neutralizing human monoclonal antibody targeting an epitope in the West Nile virus E protein preferentially recognizes mature virions

  2018cites this paper
• Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses.

  2018cites this paper
• Small Interfering RNA-Mediated Control of Virus Replication in the CNS Is Therapeutic and Enables Natural Immunity to West Nile Virus.

  2018cites this paper
• Selection of Antibody Fragments by Yeast Display.

  2018cites this paper
• FUSION OF HUMAN FC TO VHH-pa2H INCREASES BLOOD RESIDENTIAL TIME, BUT NOT BRAIN UPTAKE

  2017cites this paper
• Progress and Works in Progress: Update on Flavivirus Vaccine Development.

  2017cites this paper
• Different expression systems resulted in varied binding properties of anti-paclitaxel single-chain variable fragment antibody clone 1C2

  2017cites this paper
• Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead

  2017cites this paper
• Pre-clinical development of a hydrogen peroxide-inactivated West Nile virus vaccine.

  2017cites this paper
• Epidemiological and clinical aspects on West Nile virus, a globally emerging pathogen

  2016cites this paper
• An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection

  2016cites this paper
• Protein Targeting Compounds

  2016cites this paper
• Generation of Recombinant Antibodies Against Toxins and Viruses by Phage Display for Diagnostics and Therapy

  2016cites this paper
• West Nile Virus

  2016cites this paper
• Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display

  2016cites this paper
• Generating Recombinant Antibodies against Putative Biomarkers of Retinal Injury

  2015cites this paper
• Pathogenesis of West Nile Virus in Humans

  2015cites this paper
• Neutralizing antibodies against West Nile virus identified directly from human B cells by single-cell analysis and next generation sequencing.

  2015cites this paper
• Risk factors for West Nile virus infection and disease in populations and individuals

  2015cites this paper
• Physico-chemical requirements and kinetics of membrane fusion of flavivirus-like particles

  2015cites this paper
• Phage and Yeast Display

  2015cites this paper
• Anticorps neutralisant le coronavirus du syndrome respiratoire du moyen-orient et procédés d'utilisation de ceux-ci

  2015cites this paper
• The Antiviral Properties of Melaleuca alternifolia concentrate (MAC) against West Nile virus

  2015cites this paper
• Functional stability of 3D8 scFv, a nucleic acid-hydrolyzing single chain antibody, under different biochemical and physical conditions.

  2015cites this paper
• Fusion of hIgG1-Fc to 111In-anti-amyloid single domain antibody fragment VHH-pa2H prolongs blood residential time in APP/PS1 mice but does not increase brain uptake.

  2015cites this paper
• Combined Effects of the Structural Heterogeneity and Dynamics of Flaviviruses on Antibody Recognition

  2014cites this paper
• B Cell Response and Mechanisms of Antibody Protection to West Nile Virus

  2014cites this paper
• Systems Immunology Reveals Markers of Susceptibility to West Nile Virus Infection

  2014cites this paper
• Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution

  2014cites this paper
• Generation and characterization of a monoclonal antibody that cross‐reacts with the envelope protein from the four dengue virus serotypes

  2013cites this paper
• Development of microanalysis tools for characterization of the humoral response to infections diseases

  2013cites this paper
• Viral Membrane Fusion and Nucleocapsid Delivery into the Cytoplasm are Distinct Events in Some Flaviviruses

  2013influential citation
• Profiling the IgOme: Meeting the challenge

  2013cites this paper
• Possible Future Monoclonal Antibody (mAb)-Based Therapy against Arbovirus Infections

  2013cites this paper
• Mechanisms of Protective Activity of West Nile Virus Anti-Envelope Antibodies In vitro and In vivo

  2013cites this paper
• Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.

  2013cites this paper
• West Nile Virus: Biology, Transmission, and Human Infection

  2012cites this paper
• A Structural Perspective of Antibody Neutralization of Dengue Virus

  2012cites this paper
• Potential Therapeutics Against Flaviviruses

  2012cites this paper
• Complex phenotypes in mosquitoes and mice associated with neutralization escape of a Dengue virus type 1 monoclonal antibody.

  2012cites this paper
• In vitro and in vivo activity of AS101 against West Nile virus (WNV).

  2012cites this paper
• Phage Display Approaches for the Isolation of Monoclonal Antibodies Against Dengue Virus Envelope Domain III from Human and Mouse Derived Libraries

  2012cites this paper
• West Nile virus: characterization and diagnostic applications of monoclonal antibodies

  2012cites this paper
• Selection of antibody fragments by yeast display.

  2012cites this paper
• Structure of the St. Louis Encephalitis Virus Postfusion Envelope Trimer

  2012cites this paper
• The neutralizing human recombinant antibodies to pathogenic Orthopoxviruses derived from a phage display immune library.

  2012cites this paper
• Immunization of West Nile recombinant envelope Domain III with equine CD40 ligand protein vaccine induced specific immune response in rabbits and horses

  2012cites this paper
• Exploiting the matrix protein 2 for protection against influenza virus infection

  2012cites this paper
• Adaptive Immunity, and Viral Evasion Balance between Virulence, Innate and Pathogenesis of West Nile Virus Infection: a

  2012cites this paper
• Improved affinity of a chicken single-chain antibody to avian infectious bronchitis virus by site-directed mutagenesis of complementarity-determining region H 3

  2012influential citation
• Botrallin from the endophytic fungus Hyalodendriella sp. Ponipodef12 and its antimicrobial activity

  2011cites this paper
• The Immunopathogenesis of Neurotropic Flavivirus Infection

  2011cites this paper
• Cytoplasmic production of soluble and functional single-chain Fv-Fc fusion protein in Escherichia coli

  2011cites this paper
• Diagnosis and Prognosis of Severe Dengue

  2011cites this paper
• The Structural Basis for Flaviviridae Interaction with Antibodies and Receptors

  2011cites this paper
• Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus.

  2011cites this paper
• A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody that Recognizes a Novel Epitope within the Fusion Loop of E Protein

  2011cites this paper
• Plant production of anti-β-glucan antibodies for immunotherapy of fungal infections in humans.

  2011cites this paper
• Chimeric antibodies against tick-borne encephalitis virus.

  2010cites this paper
• The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1

  2010cites this paper
• Viral Vaccines and CTL Response

  2010cites this paper
• Nile Encephalitis Westas Immunization Vectors Protect against TLR 9-Targeted Biodegradable Nanoparticles Data

  2010cites this paper
• TLR9-Targeted Biodegradable Nanoparticles as Immunization Vectors Protect against West Nile Encephalitis

  2010cites this paper
• West Nile Encephalitis as Immunization Vectors Protect against TLR9-Targeted Biodegradable Nanoparticles

  2010cites this paper
• The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity.

  2010cites this paper
• Chapter 39 – West Nile

  2009cites this paper
• C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile Virus

  2009cites this paper
• The host immunologic response to West Nile encephalitis virus.

  2009cites this paper
• Antibody Protection and Therapy for West Nile Virus Infections

  2009cites this paper
• Clinical Manifestations of Neurological Disease

  2009cites this paper
• Human Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment Step

  2009influential citation
• Human Monoclonal Fab Antibodies Against West Nile Virus and its Neutralizing Activity Analyzed in Vitro and in Vivo.

  2009influential citation
• Fusion Loop Peptide of the West Nile Virus Envelope Protein Is Essential for Pathogenesis and Is Recognized by a Therapeutic Cross-Reactive Human Monoclonal Antibody1

  2009cites this paper
• Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus.

  2009cites this paper
• Immunotherapy of viral infections.

  2009cites this paper
• Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection

  2009cites this paper
• Towards a broadly active flavivirus therapeutic antibody

  2009cites this paper
• The Human Antibody Response Against WNV

  2009influential citation
• Novel Therapeutics Against West Nile Virus

  2009cites this paper
• Progress on the development of therapeutics against West Nile virus.

  2009cites this paper
• Monoclonal Antibody Therapeutic Cross-Reactive Human Pathogenesis and Is Recognized by a Envelope Protein Is Essential for Fusion Loop Peptide of the West Nile Virus Diamond

  2009cites this paper
• Defining the levels of secreted non‐structural protein NS1 after West Nile virus infection in cell culture and mice

  2008cites this paper
• Recombinant norovirus-specific scFv inhibit virus-like particle binding to cellular ligands

  2008cites this paper
• The structural immunology of antibody protection against West Nile virus

  2008cites this paper
• Isolation of anti-MISIIR scFv molecules from a phage display library by cell sorter biopanning

  2008cites this paper
• West Nile Virus Attenuates Activation of Primary Human Macrophages

  2008cites this paper
• Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development.

  2008cites this paper